Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
This tag page curates 5 Healthcare Stocks articles to help you assess risks, dividend potential, and notable moves from Chemed to UnitedHealth, helping smarter investment decisions.
39 articlesHims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A dramatic run in Celcuity shares drew attention from traders and long-term investors alike. This article explains th...
If you’re hunting for a lifelong holding, the dividend track record of Medtronic is hard to ignore. This piece explai...
In a world of hot bets and fast trades, one blue-chip name stands out as a potential core holding. Learn why Johnson ...
UnitedHealth stock has lagged in 2026, raising questions about its earnings, growth, and risks. This deep-dive breaks...
Digital health is redefining care delivery and costs. This guide shows how to find a high-growth healthcare stock ear...
A prominent investor takes a sizable stake in BrightSpring Health Services, sparking renewed attention on BTSG stock....
Pediatrix Medical Group stock tumbled on Thursday after earnings highlighted modest revenue pressures and GAAP vs non...
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
The Dow climbs while CRM, MSFT, and UNH slip, signaling a split market in 2026. This piece explains why the dow’s big...
UnitedHealth Group faces headwinds that go beyond routine market cycles. This guide breaks down the challenges, what ...